COVID-19 surveillance (as of 20 September 2021)
690,348
coronavirus genomes sequenced by the Sanger Institute
1,024,987
coronavirus genomes sequenced by the COVID-19 Genomics UK (COG-UK) consortium
300+
Sanger staff have contributed to the 7-days-per-week operation
Sanger Seminar: Comprehensive genomic surveillance of SARS-CoV-2 in the UK
Seminar: Exploring how the the Sanger Institute sequences SARS-CoV-2 genomes, and how this data is used by the COVID-19 Genomics UK (COG-UK) Consortium for surveillance and new variant identification; including the B.1.1.7 variant.
Q&A session with Dr Jeff Barrett, Director the Wellcome Sanger Institute COVID-19 Genomics Initiative.
Human Cell Atlas COVID-19 research
Through our collaborations within the Human Cell Atlas initiative, a number of our research teams are exploring how the SARS-CoV-2 virus interacts with the cells in the body to gain access and cause symptoms.
To find out more about this work, please visit: https://www.humancellatlas.org/covid-19/
